» Articles » PMID: 35137520

TUSC3 Inhibits Cell Proliferation and Invasion in Cervical Squamous Cell Carcinoma Via Suppression of the AKT Signalling Pathway

Overview
Journal J Cell Mol Med
Date 2022 Feb 9
PMID 35137520
Authors
Affiliations
Soon will be listed here.
Abstract

The decreased expression of tumour suppressor candidate 3 (TUSC3) is associated with proliferation in several types of cancer, leading to an unfavourable prognosis. The present study aimed to assess the cellular and molecular function of TUSC3 in patients with cervical squamous cell carcinoma (CSCC). Levels of mRNA expressions of TUSC3 were analysed in CSCC tissues and six cell lines using qRT-PCR. Immunohistochemistry(IHC) was used to evaluate the protein expression level of TUSC3 in four paired specimens, 220 paraffin-embedded CSCC specimens and 60 cases of normal cervical tissues(NCTs), respectively. Short hairpin RNA interference was employed for TUSC3 knockdown. Cell proliferation, migration and invasion were evaluated using growth curve, MTT assay, wound healing, transwell assay and xenograft tumour model, respectively. The results demonstrated that TUSC3 mRNA and protein expression levels were downregulated in CSCC samples. Multivariate and univariate analyses indicated that TUSC3 was an independent prognostic factor for patients with CSCC. Decreased TUSC3 expression levels were significantly associated with proliferation and an aggressive phenotype of cervical cancer cells both in vitro and in vivo. Moreover, the knockdown of TUSC3 promoted migration and invasion of cancer cells, while the increased expression of TUSC3 exhibited the opposite effects. The downregulation of TUSC3 facilitated proliferation and invasion of CSCC cells through the activation of the AKT signalling pathway. Our data demonstrated that the downregulation of TUSC3 promoted CSCC cell metastasis via the AKT signalling pathway. Therefore, TUSC3 may serve as a novel prognostic marker and potential target for CSCC.

Citing Articles

The Effect of the cAMP Signaling Pathway on HTR8/SV-Neo Cell Line Proliferation, Invasion, and Migration After Treatment with Forskolin.

Sun C, Mei J, Yi H, Song M, Ma Y, Huang Y Reprod Sci. 2023; 31(5):1268-1277.

PMID: 38110819 DOI: 10.1007/s43032-023-01396-5.


Maternal restricted- and over- feeding during gestation perturb offspring sperm epigenome in sheep.

Zhu L, Tillquist N, Scatolin G, Gately R, Kawaida M, Reiter A Reproduction. 2023; 166(5):311-322.

PMID: 37647207 PMC: 10962644. DOI: 10.1530/REP-23-0074.


Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis.

Deng R, Lu X, Hong C, Cai R, Wang P, Xiong L J Transl Med. 2022; 20(1):485.

PMID: 36274132 PMC: 9590144. DOI: 10.1186/s12967-022-03690-3.


TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway.

Sun F, Jie Q, Li Q, Wei Y, Li H, Yue X J Cell Mol Med. 2022; 26(5):1629-1642.

PMID: 35137520 PMC: 8899155. DOI: 10.1111/jcmm.17204.

References
1.
Noordhuis M, Fehrmann R, Wisman G, Nijhuis E, van Zanden J, Moerland P . Involvement of the TGF-beta and beta-catenin pathways in pelvic lymph node metastasis in early-stage cervical cancer. Clin Cancer Res. 2011; 17(6):1317-30. DOI: 10.1158/1078-0432.CCR-10-2320. View

2.
Xu W, Yang Z, Lu N . A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr. 2015; 9(4):317-24. PMC: 4594353. DOI: 10.1080/19336918.2015.1016686. View

3.
Gu Y, Wang Q, Guo K, Qin W, Liao W, Wang S . TUSC3 promotes colorectal cancer progression and epithelial-mesenchymal transition (EMT) through WNT/β-catenin and MAPK signalling. J Pathol. 2016; 239(1):60-71. DOI: 10.1002/path.4697. View

4.
Zhang Y, He R, Dang Y, Zhang X, Wang X, Huang S . Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells. Cancer Cell Int. 2016; 16:89. PMC: 5133743. DOI: 10.1186/s12935-016-0366-6. View

5.
Pappa K, Kontostathi G, Makridakis M, Lygirou V, Zoidakis J, Daskalakis G . High Resolution Proteomic Analysis of the Cervical Cancer Cell Lines Secretome Documents Deregulation of Multiple Proteases. Cancer Genomics Proteomics. 2017; 14(6):507-521. PMC: 6070321. DOI: 10.21873/cgp.20060. View